021-51111890
购物车（）
sales@molnova.cn
Ademetionine(b)
CAS No. 29908-03-0
Ademetionine(b) ( S-Adenosyl-L-methionine; S-Adenosyl methionine; SAMe; AdoMet )
产品货号. M20824 CAS No. 29908-03-0
Ademetionine is an intermediate metabolite of methioninefor treatment of primary biliary cirrhosis and major depressive disorder.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | ￥2989 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ademetionine(b)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ademetionine is an intermediate metabolite of methioninefor treatment of primary biliary cirrhosis and major depressive disorder.
-
产品描述Ademetionine is an intermediate metabolite of methioninefor treatment of primary biliary cirrhosis and major depressive disorder.
-
同义词S-Adenosyl-L-methionine; S-Adenosyl methionine; SAMe; AdoMet
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Neurological Disease
-
适应症Major depressive disorder
化学信息
-
CAS Number29908-03-0
-
分子量398.44
-
分子式C15H22N6O5S
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (250.98 mM);H2O:43 mg/mL (107.92 mM)
-
SMILESC[S+](CCC(N)C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O
-
化学全称(2S)-2-amino-4-((((2S3S4R5R)-5-(6-amino-9H-purin-9-yl)-34-dihydroxytetrahydrofuran-2-yl)methyl)(methyl)sulfonio)butanoate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ivashkin V T Maevskaya M V Kobalava Z D et al. Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease.[J]. Minerva Gastroenterologica E Dietologica 2018.
产品手册
关联产品
-
Angiogenin 108-122
Angiogenin (108-122) is an angiogenin peptide. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease.
-
Neuropeptide AF (93-...
Neuropeptide AF (93-110), Human is an endogenous antiopioid peptide.
-
Halleridone
halleridone activated Nrf2-mediated HO-1 expression and inhibited Aβ1-42-overexpressed microglial BV-2 cell activation.
